Insider · CIK 0001565832
Sergio Traversa
Files at RLMD (RELMADA THERAPEUTICS, INC.). First filing May 20, 2025, latest Sep 11, 2026.
In brief
Sergio Traversa files SEC Form 4 as CEO and director at RLMD (RELMADA THERAPEUTICS, INC.). Since May 20, 2025, Sergio Traversa has reported 5 open-market buys worth $1.9M and 0 open-market sells worth $0, the latest filed on Sep 11, 2026.
A track record needs three past buys with six months of prices behind them; Sergio Traversa has 0, so none is measured yet.
The newest scored trade: bought $828k of RLMD on Sep 9, 2026, filed Sep 11, 2026, scored 59 (moderate). In the last 12 months: 3 buys worth $1.5M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RLMD: RELMADA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 59Moderate | RELMADA THERAPEUTICS, INC. | $828k 200,000 shares | +15% | - | |
| 48Moderate | RELMADA THERAPEUTICS, INC. | $113k 27,500 shares | +2% | +1630% from low-3% from high | |
| 74Notable | RELMADA THERAPEUTICS, INC. | $600k 272,500 shares | +27% | +896% from low-26% from high | |
| 51Moderate | RLMDbuy RELMADA THERAPEUTICS, INC. | $178k 265,976 shares | +36% | +162% from low-82% from high | |
| 69Notable | RELMADA THERAPEUTICS, INC. | $175k 350,000 shares | +91% | +83% from low-87% from high |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +100,000 | $4.18 | $418k | 1,400,000 | 32 d ago |
| Sep 10, 2026 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +100,000 | $4.10 | $410k | 1,500,000 | 32 d ago |
| Dec 15, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +27,500 | $4.12 | $113k | 1,300,000 | Dec 16, 2025 |
| Dec 12, 2025 | RLMD RELMADA THERAPEUTICS, INC. | AGrant or award Stock Appreciation Rightsderivative | +1,198,000 | $0.00 | $0 | 1,198,000 | Dec 16, 2025 |
| Nov 5, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +272,500 | $2.20 | $600k | 1,272,500 | Nov 6, 2025 |
| Aug 26, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +80,545 | $0.62 | $50k | 814,569 | Aug 28, 2025 |
| Aug 27, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +129,455 | $0.67 | $87k | 944,024 | Aug 28, 2025 |
| Aug 28, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +55,976 | $0.74 | $41k | 1,000,000 | Aug 28, 2025 |
| Jun 26, 2025 | RLMD RELMADA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Jun 30, 2025 |
| May 16, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +172,314 | $0.45 | $77k | 556,338 | May 20, 2025 |
| May 19, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +30,000 | $0.50 | $15k | 586,338 | May 20, 2025 |
| May 20, 2025 | RLMD RELMADA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +147,686 | $0.56 | $82k | 734,024 | May 20, 2025 |
| Dec 15, 2023 | RLMD RELMADA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +183,881 | $0.00 | $0 | 183,881 | Dec 19, 2023 |
Questions about Sergio Traversa
Answered from the filings on this page, as of the latest one.
Is Sergio Traversa buying or selling?
In the last 12 months Sergio Traversa reported 3 open-market buys worth $1.5M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $828k of RLMD on Sep 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Sergio Traversa's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sergio Traversa has 0.
Where does Sergio Traversa file Form 4?
Sergio Traversa has filed Form 4 at RLMD (RELMADA THERAPEUTICS, INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.